Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma

See also
Status	Clinical Trial	Phase
Completed	`NCT00038025` - A Study Of Deoxycoformycin(DCF)/Pentostatin In Lymphoid Malignancies	Phase 2
Recruiting	`NCT02445404` - Compare Efficacy of CHOP Versus Fractionated ICED in Transplant-eligible Patients With Previously Untreated PTCL	Phase 2
Completed	`NCT02168140` - CPI-613 and Bendamustine Hydrochloride in Treating Patients With Relapsed or Refractory T-Cell Non-Hodgkin Lymphoma or Hodgkin Lymphoma	Phase 1
Terminated	`NCT01644253` - Phase 1b Safety and Efficacy Study of TRU-016	Phase 1
Completed	`NCT01689220` - A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL) in Korea	Phase 1
Completed	`NCT01435863` - A Phase 1 Study of SP-02L in Relapsed or Refractory Patients With Peripheral T-cell Lymphoma (PTCL)	Phase 1
Completed	`NCT01427881` - Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies	Phase 2
Terminated	`NCT00441025` - The Effectiveness of Alemtuzumab Combination With CHOP to Treat Patients Newly Diagnosed With PTCL	Phase 2
Completed	`NCT00078858` - Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant	Phase 1/Phase 2
Completed	`NCT00003196` - Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma	N/A
Active, not recruiting	`NCT04312841` - Letermovir for the Prevention of Cytomegalovirus Reactivation in Patients With Hematological Malignancies Treated With Alemtuzumab	Phase 2
Recruiting	`NCT04040491` - PD-1 Antibody, Chidamide, Lenalidomide and Gemcitabine for Peripheral T-cell Lymphoma	Phase 4
Terminated	`NCT01678443` - Monoclonal Antibody Therapy Before Stem Cell Transplant in Treating Patients With Relapsed or Refractory Lymphoid Malignancies	Phase 1
Completed	`NCT01588015` - Vaccine Therapy in Preventing Cytomegalovirus Infection in Patients With Hematological Malignancies Undergoing Donor Stem Cell Transplant	Phase 1
Completed	`NCT02264613` - ALRN-6924 in Patients With Advanced Solid Tumors or Lymphomas	Phase 1/Phase 2
Completed	`NCT02142530` - Carfilzomib Plus Belinostat in Relapsed/Refractory NHL	Phase 1
Terminated	`NCT01408043` - Etoposide, Filgrastim, and Plerixafor in Improving Stem Cell Mobilization in Treating Patients With Non-Hodgkin Lymphoma	N/A
Completed	`NCT00131937` - Sorafenib Tosylate in Treating Patients With Recurrent Aggressive Non-Hodgkin's Lymphoma	Phase 2
Completed	`NCT00791947` - A Nordic Phase II Study of PTCL Based on Dose-intensive Induction and High-dose Consolidation With ASCT	Phase 2
Recruiting	`NCT04880746` - Efficacy and Safety of Cladribine Combined With BEAC Pretreatment Regimen in the Treatment of Peripheral T-cell Lymphoma: a Multicenter Clinical Study	Phase 3

NCT number	NCT06422247
Study type	Observational
Source	Bristol-Myers Squibb
Contact	BMS Study Connect Contact Center www.BMSStudyConnect.com
Phone	855-907-3286
Email	Clinical.Trials@bms.com
Status	Recruiting
Phase
Start date	June 14, 2024
Completion date	April 30, 2025

Observational Study in Japanese Patients With Peripheral T-Cell Lymphoma Who Received Second-Line Therapy

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms